J. Goldman & Co’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-21,137
Closed -$224K 450
2024
Q1
$224K Buy
+21,137
New +$185K 0.01% 359
2016
Q2
Sell
-15,500
Closed -$408K 327
2016
Q1
$408K Buy
+15,500
New +$1.15M 0.03% 261

Other funds holding BHC

J. Goldman & Co's BHC Position: Q2 2024 in Review

J. Goldman & Co sold out of Bausch Health (BHC) in Q2 2024, closing a stake of 21,137 shares — an estimated $224K sold.

J. Goldman & Co first reported a position in BHC in Q1 2016 and held it in 2 quarters. The position peaked at $408K in Q1 2016. 234 funds tracked by Wall St. Rank hold BHC as of Q2 2024.

  • J. Goldman & Co reported no remaining Bausch Health position as of Q2 2024 after selling out during the quarter.
  • J. Goldman & Co sold 21,137 Bausch Health shares in Q2 2024, an estimated $224K.
  • J. Goldman & Co first reported a position in Bausch Health in Q1 2016 and held it in 2 quarters.
  • J. Goldman & Co's Bausch Health position peaked at $408K in Q1 2016.
  • 234 funds tracked by Wall St. Rank held Bausch Health as of Q2 2024.

Based on J. Goldman & Co's 13F filing for Q2 2024, filed 14 Aug 2024.